3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

For the SCALE Obesity Prediabetes NN8022-1839 Study Group

    Research output: Contribution to journalArticlepeer-review

    514 Scopus citations

    Fingerprint

    Dive into the research topics of '3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences